Related Experiment Video
Updated: Jan 5, 2026
Diffusion Tensor Magnetic Resonance Imaging in the Analysis of Neurodegenerative Diseases
Published on: July 28, 2013
Diffusion Tensor MRI to Distinguish Progressive Supranuclear Palsy from α-Synucleinopathies
Nicola Spotorno1, Sara Hall1, David J Irwin1
1From the Clinical Memory Research Unit, Department of Clinical Sciences, Malmö, Lund University, Sölvegatan 19, 22100 Lund, Sweden (N.S., S.H., D.v.W., O.H.); Penn Frontotemporal Degeneration Center, Department of Neurology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pa (N.S., D.J.I., M.G., C.T.M.); Memory Clinic, Skåne University Hospital, Malmö, Sweden (S.H., O.H.); Center for Neurodegenerative Disease Research, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pa (D.J.I., E.B.L., J.Q.T.); Department of Diagnostic Radiology, Lund University, Lund, Sweden (T.R., D.v.W., M.N.); Wellcome Centre for Human Neuroimaging, UCL Queen Square Institute of Neurology, University College London, London, England (J.A.C.); Parkinson's Disease and Movement Disorders Center, Department of Neurology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pa (A.F.D., M.A.S.); Alzheimer's Disease Core Center, Department of Pathology and Laboratory Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pa (E.B.L., J.Q.T.); and Queensland Brain Institute, University of Queensland and Mater Misericordiae, Brisbane, Queensland, Australia (P.J.N.).
A new diffusion tensor imaging (DTI) fractional anisotropy (FA) score effectively distinguishes progressive supranuclear palsy (PSP) from Lewy body disorders. This tool shows high accuracy, laying the groundwork for a reliable clinical diagnostic test.
Area of Science:
- Neuroimaging
- Neurology
- Radiology
Background:
- Diagnosing progressive supranuclear palsy (PSP) and Lewy body disorders (LBD) is challenging due to overlapping clinical symptoms.
- Accurate differentiation is crucial for appropriate patient management and treatment.
Purpose of the Study:
- To develop and validate a diffusion tensor imaging (DTI) based tool for distinguishing PSP from LBD at the individual subject level.
- To identify specific neuroimaging biomarkers indicative of PSP pathology.
Main Methods:
- Retrospective analysis of two independent cohorts (discovery and validation) using skeletonized DTI metrics.
- Calculation of a fractional anisotropy (FA) score based on regions sensitive to PSP pathology (superior cerebellar peduncle, frontal white matter).
- Classification performance assessed using logistic regression and receiver operating characteristic analysis.
Main Results:
- In the discovery cohort, the FA score achieved an area under the curve (AUC) of 0.97 (94% sensitivity, 91% specificity) for distinguishing PSP from LBD.
- Validation cohort confirmed the FA score's accuracy with an AUC of 0.96 (85% sensitivity, 96% specificity).
- The FA score demonstrated robust performance in differentiating PSP from LBD across both datasets.
Conclusions:
- The developed FA score serves as a promising tool for the differential diagnosis of PSP and LBD.
- These findings support the potential for a novel, non-invasive clinical test to aid in distinguishing these neurodegenerative conditions.
- Cross-validated results provide a strong foundation for future clinical implementation.
Related Concept Videos
01:17Assessment of Diffusion and Perfusion
The Role of Diffusion in Respiration
Diffusion is the process by which molecules move from an area of higher concentration to an area of lower concentration. In the respiratory system, this...
01:24Magnetic Resonance Imaging